Amgen (AMGN)

Featured here, the Balance Sheet for Amgen, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

221.30 -0.20 (-0.09%)

30/03 Closed EUR Disclaimer

AMGN Balance Sheet

Total Current Assets

Name	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Current Assets	22,186	24,062	19,322	18,520	19,385
Cash and Short Term Investments	9,305	11,478	7,183	6,544	8,037
Cash	-	-	-	-	-
Cash & Equivalents	7,629	9,502	5,203	6,528	7,989
Short Term Investments	1,676	1,976	1,980	16	48
Total Receivables, Net	6,392	5,326	5,327	5,077	5,839
Accounts Receivables - Trade, Net	5,563	5,326	5,327	5,077	4,895
Total Inventory	4,930	4,757	4,554	4,411	4,086
Prepaid Expenses	1,204	1,223	-	-	-
Other Current Assets, Total	355	2,501	2,258	2,488	200
Total Assets	65,121	63,700	59,294	59,196	61,165
Property/Plant/Equipment, Total - Net	6,006	5,188	5,158	5,142	5,750
Property/Plant/Equipment, Total - Gross	15,289	14,388	14,158	14,042	14,548
Accumulated Depreciation, Total	-9,283	-9,200	-9,000	-8,900	-8,798
Goodwill, Net	15,529	14,845	14,865	14,897	14,890
Intangibles, Net	16,080	13,266	13,927	14,567	15,182
Long Term Investments	3,162	874	979	1,137	4,503
Note Receivable - Long Term	829	944	-	-	-
Other Long Term Assets, Total	2,158	5,465	5,043	4,933	1,455
Other Assets, Total	569	3,908	3,465	1,838	-1,505
Total Current Liabilities	15,687	14,331	12,618	12,886	12,184
Accounts Payable	1,572	1,204	1,256	1,403	1,366
Payable/Accrued	-	-	-	-	-
Accrued Expenses	9,488	11,584	10,545	10,639	8,260
Notes Payable/Short Term Debt	-	-	-	-	-
Current Port. of LT Debt/Capital Leases	1,747	1,543	817	844	232
Other Current liabilities, Total	2,880	0	0	0	2,326
Total Liabilities	61,460	60,047	56,875	58,280	54,465
Total Long Term Debt	37,354	37,161	35,705	36,010	33,222
Long Term Debt	37,354	37,161	35,705	36,010	33,222
Capital Lease Obligations	-	-	-	-	-
Deferred Income Tax	-	-	-	-	-
Minority Interest	-	-	-	-	-
Other Liabilities, Total	8,419	8,555	8,552	9,384	9,059
Total Equity	3,661	3,653	2,419	916	6,700
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	32,514	32,371	31,343	31,247	32,096
Additional Paid-In Capital	-	-	-	-	-
Retained Earnings (Accumulated Deficit)	-28,622	-28,066	-28,252	-29,568	-24,600
Treasury Stock - Common	-	-	-	-	-
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-	-
Other Equity, Total	-231	-652	-672	-763	-796
Total Liabilities & Shareholders' Equity	65,121	63,700	59,294	59,196	61,165
Total Common Shares Outstanding	534	533.50	534.90	534.20	558.30
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.